121 related articles for article (PubMed ID: 23443454)
1. Coding of specific subgroups of myelodysplastic syndromes in a population-based cancer registry: prospects for improvement.
Polednak AP; Phillips C
J Registry Manag; 2012; 39(3):107-14. PubMed ID: 23443454
[TBL] [Abstract][Full Text] [Related]
2. Leukemia as a cause of death among patients with myelodysplastic syndromes (MDS) in a population- based cancer registry: improving estimates of MDS-related mortality in the population.
Polednak AP; Phillips C
J Registry Manag; 2012; 39(3):115-20. PubMed ID: 23443455
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.
Komrokji RS; Matacia-Murphy GM; Al Ali NH; Beg MS; Safa MM; Rollison DE; List AF
Leuk Res; 2010 Jan; 34(1):59-62. PubMed ID: 19368972
[TBL] [Abstract][Full Text] [Related]
4. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.
Dinmohamed AG; Visser O; van Norden Y; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
Eur J Cancer; 2014 Mar; 50(5):1004-12. PubMed ID: 24388662
[TBL] [Abstract][Full Text] [Related]
5. Cancers coded as tongue not otherwise specified: relevance to surveillance of human papillomavirus-related cancers.
Polednak AP; Phillips C
J Registry Manag; 2014; 41(4):190-5. PubMed ID: 25803632
[TBL] [Abstract][Full Text] [Related]
6. High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment.
Cogle CR; Iannacone MR; Yu D; Cole AL; Imanirad I; Yan L; Mackinnon JA; List AF; Rollison DE
Leuk Res; 2014 Jan; 38(1):71-5. PubMed ID: 24280283
[TBL] [Abstract][Full Text] [Related]
7. Clustering in the incidence of myelodysplastic syndromes.
Ma X; Selvin S; Raza A; Foti K; Mayne ST
Leuk Res; 2007 Dec; 31(12):1683-6. PubMed ID: 17507092
[TBL] [Abstract][Full Text] [Related]
8. [Myelodysplastic syndromes. The epidemiological and etiological aspects].
Aul C; Gattermann N; Germing U; Runde V; Heyll A
Dtsch Med Wochenschr; 1992 Aug; 117(33):1223-31. PubMed ID: 1499520
[TBL] [Abstract][Full Text] [Related]
9. Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006.
De Roos AJ; Deeg HJ; Onstad L; Kopecky KJ; Bowles EJ; Yong M; Fryzek J; Davis S
Am J Hematol; 2010 Oct; 85(10):765-70. PubMed ID: 20815079
[TBL] [Abstract][Full Text] [Related]
10. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
11. A comparative review of classification systems in myelodysplastic syndromes (MDS).
Bennett JM
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
[TBL] [Abstract][Full Text] [Related]
12. MDS classification is improving in an era of the WHO 2016 criteria of MDS: A population-based analysis among 9159 MDS patients diagnosed in the Netherlands.
Dinmohamed AG; Visser O; Posthuma EFM; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
Cancer Epidemiol; 2017 Oct; 50(Pt A):137-140. PubMed ID: 28910695
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of US deaths related to myelodysplastic syndromes, and the need for linkages with central cancer registries.
Polednak AP
J Registry Manag; 2011; 38(4):183-9. PubMed ID: 23270091
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndromes: incidence and survival in the United States.
Ma X; Does M; Raza A; Mayne ST
Cancer; 2007 Apr; 109(8):1536-42. PubMed ID: 17345612
[TBL] [Abstract][Full Text] [Related]
15. [Myelodysplastic syndromes].
Paladini G; Pecorari P; De Sabbata G; Sammartini C
Recenti Prog Med; 2004 Feb; 95(2):108-19. PubMed ID: 15072397
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndromes classification and risk stratification.
Komrokji RS; Zhang L; Bennett JM
Hematol Oncol Clin North Am; 2010 Apr; 24(2):443-57. PubMed ID: 20359636
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.
Germing U; Aul C; Niemeyer CM; Haas R; Bennett JM
Ann Hematol; 2008 Sep; 87(9):691-9. PubMed ID: 18575866
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
[TBL] [Abstract][Full Text] [Related]
19. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
20. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
